Intussusception Market Research, to Offer Significant Growth Opportunities by 2030

The Intussusception Market is anticipated to reach USD 5,802.37 Million by 2030 at 4.20% CAGR during the forecast period 2022-2030.


Market Highlights

The Intussusception Market Report is anticipated to reach USD 5,802.37 Million by 2030 at 4.20% CAGR during the forecast period 2022-2030.

Intussusception, also known as intestinal obstruction, is a potentially fatal disorder caused by the folding of one portion of the intestine into another, resulting in a bowel blockage. The obstruction obstructs the excretion process. Intussusception is the most common problem in children between 2 months to 2 years. Adults, on the other hand, maybe impacted by intussusception. It usually happens at the junction of the small and large intestines. Tumors, inflammation, Meckel's diverticulum, duplication, appendix, hyperplasia of Peyer's patches, intestinal surgery, polyps, tumors, inflammation, and other factors can all contribute to it. It induces tissue death by blocking the blood supply to the intestine. Infection, internal bleeding, ripping, intestinal injury, and peritonitis can all result from tissue death.

Intussusception, also called bowel obstruction, is obstruction of the intestine due to folding of one part of the intestine into another part which prevents food and waste from properly passing through the body. Intussusception is common in children between 2 months and 2 years of age and adults are rarely affected by it. Intussusception is also more common where the small and large intestines meet.

Global Intussusception Market Players

Some of the key Intussusception Market Players profiled in the report are Pfizer, Inc., Janssen Pharmaceuticals, Inc., Abbott, GlaxoSmithKline plc, Sanofi Aventis U.S. LLC., Novartis AG, Bayer AG, Fujifilm Holdings Corporation, General Electric Company, Shimadzu Corporation, Carestream Health, Bristol-Myers Squibb Company, and others.


The global Intussusception Market Research has been segmented on the basis of type, diagnosis, treatment, and end user.

  • Based on type, the market has been segmented as Ileoileal, Ileocolic, Ileo-ileo-colic and others.
  • Based on diagnosis, the market has been segmented as barium enema, ultrasound, X-ray, computerized tomography (CT), and others.
  • Based on surgery, the market has been segmented as surgery, drugs, and others.
  • Based on the end user, the market has been segmented as hospitals clinics, academic and research, and others.

Regional Analysis

The Americas accounts for a significant Share owing to extensive volume of surgeries performed and high expenditure on the health care. The fast uptake of new products and surgical procedures in the US drive the intussusception market. The US has a greater healthcare public expenditure about 16% of GDP, which stimulates the sale of Intussusception treatment. The presence of major healthcare companies in the developed countries of this region coupled with the larger insurance penetration is adding fuel to the market growth.

Europe is the second largest market in the world due to high income and strong healthcare penetration. European market growth is led by countries such as Germany and France. The presence of large medical devices companies in Germany drives the market for surgery segment in Europe. The UK is expected to be the fastest growing market over the assessment period.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs during the forecast period. South East Asian countries such as Vietnam, Thailand, and Malaysia are projected to contribute highly to the market growth in the future.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt, and Iran. The development of large hospitals and the concurrent expansion of public health facilities by the gulf nations is expected to drive the future market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. The lack of democracy has resulted in lower degree of power of the masses, which are unable to demand greater public expenditure on healthcare, which has constrained the market in African sub-Saharan countries.

Related Report-


About Market Research Future:  At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013